CClinicalTrials.gg
RecruitingNCT06088225DISUpdated Oct 24, 2023

Myopia Preventing With Distance-image Screen

An interventional study of distance-image screen in Myopia, Progressive, sponsored by Beijing Airdoc Technology Co., Ltd.. Recruiting at 1 site in China. Open to participants aged 6 Years to 12 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-10-24.

Sponsored by Beijing Airdoc Technology Co., Ltd. · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Primary completion was expected by Dec 2024, 1 year 9 months ago, but the record still lists the study as recruiting.
  • Registered 1 year after the study started (first participant enrolled Oct 2022, registered Oct 2023).
  • Started Oct 2022; still recruiting 4 years later.
Phase
Not applicable
Study type
Interventional
Enrollment
100
Allocation
Not applicable
Ages
6 Years to 12 Years
Sex
All
01

Study summary

This study is for testing the efficacy and safety of distance-image screens for preventing myopia in children for 12 month. Each subjects would be asked to paired test the ocular parameters between before and after 12-month distance-image screens.

Read the detailed description

This study is for testing the efficacy and safety of distance-image screens intended usage for preventing myopia in children with reading after a 6-meter-distant-image device. It was a prospective study. The investigators would like to recruit 100 volunteers, aged 6 years 16 in Beijing.

All the volunteers will be complete examined their ocular parameters before using the distant-image screen in a random order for at least 2 hours daily for 12 month. The changes of ocular axial length and refractive error were both calculated before and after 12-month usage for paired t-test.

02

Conditions studied

  • Myopia, Progressive

Keywords

  • Myopia; children
03

In context

Myopia

984 studies on the registry are indexed under Myopia; 210 are open to participants now.

This study's planned enrollment of 100 is above the median of 80 across 783 interventional studies indexed under Myopia.

Browse Myopia studies →

Lead sponsor

Beijing Airdoc Technology Co., Ltd. is the lead sponsor of 8 studies on the registry; 5 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
6 Years to 12 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • (1) Must be 6\~12 years old;
  • (2) Must be best corrected visual acuity \< logMAR: 0.1;
  • (3) Spherical Equivalence (SE) must be -1.00\~ + 6.00 Diopter (D),
  • (4) Spherical Equivalence (SE) must have changed > 1.25 Diopter (D) in the recent 2 years;
  • (5) Must be astigmatism \<1.75 Diopter (D);
  • (6) Must be anisometropia \<1.75 Diopter(D).

Exclusion criteria

Exclusion Criteria:

  • (1) Strabismus disease;
  • (2) Amblyopia disease;
  • (3) Cataract disease;
  • (4) Glaucoma disease;
  • (5) Severe dry eye disease;
  • (6) Cannot use distance-image screen for 12 month;
  • (7) Other severe diseases that would effect the use of distance-image screen.
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
100 participants (estimated)

Study arms

  • Experimental
    Distance -image screen

    Distance -image screen is a device to make image in the distance of 6-meters when reading and learning at near. The investigators will ask the subjects to use the distance - image screen for 12 month

    Device: distance-image screen

Interventions

  • Devicedistance-image screen

    Distance-image screen is a screen make each image at distance of 6-meters to reduce the accommodation and convergence for eyes during the reading and learning with screens.

06

What researchers measure

Primary outcomes

  1. Changes of ocular axial length (mm)

    IntraOcularLens (IOL) master biometry will exam each eye before the testing and after the testing with distance-image screen

    Time frame: 12-month

  2. Changes of refractive error (D)

    Cycloplegic refraction with autorefractor will test each eye before the testing and after the testing with distance-image screen

    Time frame: 12-month

Secondary outcomes

  1. Changes of center macular thickness (um)

    Optic Coherent Topograph (OCT) of macular fovea central thickness will be made to compare the thickness before and after using distance-image screen

    Time frame: 12-month

  2. Changes of subretina choroidal thickness (um)

    Optic Coherent Topograph (OCT) with Enhanced Depth Imaging (EDI) scan of macular fovea central thickness will be done to compare the thickness before and after using distance-image screen

    Time frame: at 12-month

  3. Changes of other regions choroidal thickness (um)

    Optic Coherent Topograph (OCT) with Enhanced Depth Imaging (EDI) scan of other regions choroidal thickness will be done to compare the thickness before and after using distance-image screen

    Time frame: 12-month

07

Study locations

1 of 1 sites recruiting
  • Airdoc MPC Opthalmology Clinics
    Beijing, Beijing 100089, China
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 24, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06088225
Lead sponsor
Beijing Airdoc Technology Co., Ltd.
Responsible party
Sponsor
First posted
Oct 18, 2023
Start date
Oct 1, 2022
Primary completion
Dec 31, 2024 (estimated)
Completion
Dec 31, 2026 (estimated)
Last update
Oct 24, 2023

Study contacts

QIU JENNY, MD
Contact
kkaiqiu@126.com
+8618510386815
Huadong AI, OD
Contact
aihuadong@airdoc.com

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion